DH - NASDAQ

Definitive Healthcare Corp.

DH·NASDAQ

$0.91

+3.9%

HealthcareMedical - Healthcare Information Services

Definitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United States. Its solutions provide information on healthcare providers and their activities to help its customers in the area ranging from product development to go-to-market planning, and sales and marketing execution. The company's platform offers 16 intelligence modules that cover functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate companies, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$95.74M

EPS-1.3000

P/E Ratio-0.70

Earnings Date08/06/2026

735.49M

Assets

-32%

3Y-65.0%

5Y-58.0%

10Y-57.0%

356.50M

Total Liabilities

-26%

3Y-44.0%

5Y-35.0%

10Y-29.0%

378.99M

Total Equity

-38%

3Y-74.0%

5Y-68.0%

10Y-69.0%

Definitive Healthcare Corp. Funding & Solvency Profile

DH · NASDAQ

Current Assets

Cash & Cash Equivalents163.63M

Net Receivables51.98M

Inventory0.00

Other Current Assets24.74M

Total Current Assets258 M

Non-Current Assets

Property, Plant & Equipment18.07M

Goodwill & Intangible Assets444.70M

Long-Term Investments0.00

Other Non-Current Assets15.12M

Total Non-Current Assets33 M

Total Assets

735.49M

Financial Health Analysis

Current Ratio

1.64x

Strong liquidity. The company has adequate resources to meet short-term liabilities.

Debt-to-Equity Ratio

0.94x

Balanced capital structure with moderate leverage. Equity exceeds debt, suggesting healthy financial stability.

Working Capital

101 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

35% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

Financial Health Insight

Strong financial foundation: Excellent liquidity combined with conservative leverage suggests the company is well-positioned to weather economic uncertainties and fund growth opportunities.

Definitive Healthcare Corp. Balance Sheet

DH • NASDAQ

Definitive Healthcare Corp. Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	163.6M	105.4M	131M	146.9M	387.5M	24.8M	8.6M
Short-Term Investments	17.3M	184.8M	177.1M	184.9M	0.0	0.0	0.0
Cash & Short-Term Investments	180.9M	290.2M	308.1M	331.9M	387.5M	24.8M	8.6M
Net Receivables	52M	53.2M	59.2M	58.8M	43.3M	33.1M	25M
Accounts Receivables	52M	52.5M	59.2M	57.9M	42.9M	33.1M	25M
Other Receivables	0.0	728K	0.0	881K	430K	0.0	0.0
Prepaids	0.0	0.0	0.0	0.0	6.5M	3M	1.7M
Other Current Assets	24.7M	26.8M	13.1M	23.1M	6.9M	2.9M	769K
Total Current Assets	257.6M	370.2M	380.4M	413.7M	444.2M	63.8M	36.1M
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	18.1M	11.3M	14.1M	14.1M	5.1M	3.2M	2.6M
Goodwill	197.2M	393.3M	1.1B	1.3B	1.3B	1.3B	1.2B
Intangible Assets	247.5M	297.9M	323.1M	350.7M	352.5M	410.2M	446.4M
Goodwill & Intangible Assets	444.7M	691.2M	1.4B	1.7B	1.6B	1.7B	1.7B
Long-Term Investments	0.0	0.0	509K	0.0	32.7M	6M	2.1M
Tax Assets	0.0	0.0	0.0	0.0	158K	161K	212K
Other Non-Current Assets	15.1M	16.7M	19.2M	19.3M	19.9M	472K	607K
Total Non-Current Assets	477.9M	719.2M	1.4B	1.7B	1.7B	1.7B	1.7B
Other Assets	0.0	0.0	13.5M	0.0	0.0	0.0	0.0
Total Assets	735.5M	1.1B	1.8B	2.1B	2.1B	1.7B	1.7B
LIABILITIES
CURRENT LIABILITIES
Total Payables	3.6M	26.4M	5.8M	15.7M	11.9M	5.7M	2.2M
Accounts Payable	3.6M	10.8M	5.8M	3.9M	4.7M	5.7M	2.2M
Other Payables	0.0	15.7M	0.0	11.7M	7.2M	0.0	0.0
Accrued Expenses	0.0	0.0	12.8M	12M	17.8M	14.7M	3.9M
Short Term Debt	11.4M	13.8M	13.8M	8.6M	6.9M	4.7M	4.5M
Capital Lease Obligations (Current)	0.0	2.4M	2.2M	1.5M	0.0	0.0	-39.9M
Tax Payables	0.0	15.7M	29.6M	11.7M	7.2M	649K	1.9M
Deferred Revenue	97M	93.3M	97.4M	99.7M	83.6M	61.6M	46M
Other Current Liabilities	44.8M	25.2M	38.7M	3.2M	3M	2.1M	53.3M
Total Current Liabilities	156.8M	161.2M	170.7M	140.6M	123.1M	88.7M	69.9M
NON-CURRENT LIABILITIES
Long Term Debt	161.2M	229.4M	242.6M	255.8M	263.8M	457.2M	434.8M
Deferred Revenue (Non-Current)	2.4M	32K	9K	236K	412K	140K	148K
Deferred Tax Liabilities (Non-Current)	14.6M	25.1M	67.2M	75.7M	76.4M	0.0	434.8M
Other Non-Current Liabilities	16.3M	59M	136.9M	158.4M	154M	3.7M	0.0
Total Non-Current Liabilities	199.7M	321M	456M	500.1M	494.7M	461.1M	435M
Capital Lease Obligations	5.2M	10M	11.6M	11.5M	0.0	0.0	0.0
Total Liabilities	356.5M	482.2M	626.7M	640.7M	617.8M	549.8M	504.9M
SHAREHOLDERS' EQUITY
Common Stock	104K	114K	117K	105K	97K	1.3B	1.3B
Additional Paid-In Capital	1.1B	1.1B	1.1B	970.2M	889M	0.0	0.0
Retained Earnings	-779.5M	-640.6M	-227.5M	-25.1M	-17.8M	-109.9M	-55.8M
Accumulated Other Comprehensive Income/Loss	-1.5M	-610K	2.1M	3.7M	62K	-131K	0.0
Total Stockholders' Equity	281.1M	444.4M	861.4M	948.9M	871.3M	1.2B	1.2B
Total Equity	379M	607.2M	1.2B	1.5B	1.5B	1.2B	1.2B
Minority Interest	97.9M	162.8M	337.8M	533M	628.5M	0.0	0.0
SUMMARY
Total Liabilities & Equity	735.5M	1.1B	1.8B	2.1B	2.1B	1.7B	1.7B
Total Investments	17.3M	184.8M	177.6M	184.9M	32.7M	6M	2.1M
Total Debt	177.8M	253.1M	267.9M	275.8M	270.7M	461.9M	439.3M
Net Debt	14.2M	147.7M	137M	128.9M	-116.8M	437.1M	430.7M
Shares Outstanding	104,086,210	104,086,210	104,086,210	104,086,210	104,086,210	104,086,210	104,086,210

SEC Filings

DH - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
10-Q 10-Q 2026 Q1 Q1	May 07, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 07, 2026	May 07, 2026	2026	View Filing
DEF 14A DEF 14A 2026 N/A	April 23, 2026	June 04, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 09, 2026	April 03, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 03, 2026	March 30, 2026	2026	View Filing
10-K 10-K 2025 FY FY	February 26, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	February 26, 2026	February 26, 2026	2026	View Filing
10-Q 10-Q 2025 Q3 Q3	November 06, 2025	September 30, 2025	2025	View Filing
8-K 8-K 2025 N/A	November 06, 2025	November 06, 2025	2025	View Filing
10-Q 10-Q 2025 Q2 Q2	August 07, 2025	June 30, 2025	2025	View Filing

Showing 1 to 10 of 75 filings

Related Guides

Blog Categories

Continue your DH research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.